Next, we further analyzed the relationship between the clinicopathological characteristics of glioma patients and found that the expression of GINS4 was positively correlated with WHO grade, IDH mutation, 1p19 codeletion, PRS_type, and histological subtypes of glioma patients. This evidence concerns the gene GINS4 and central nervous system cancer.